Related Experiment Video

Updated: Jun 4, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells

Giorgio Zauli1, Rebecca Voltan, Maria Grazia di Iasio

  • 1Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|March 4, 2011
PubMed
Abstract

Insights

This study reveals that miR-34a can downregulate oncogenes B-Myb and E2F1, crucial for leukemia cell-cycle progression. Modulating miR-34a offers a potential therapeutic strategy for leukemia.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • B-Myb and E2F1 are key oncogenes driving cell-cycle progression in leukemia.
  • Understanding mechanisms to downregulate these oncogenes is critical for developing novel cancer therapies.

Purpose of the Study:

  • To identify molecular mechanisms capable of downregulating B-Myb and E2F1 mRNA levels.
  • To explore the therapeutic potential of targeting these oncogenes in leukemia.

Main Methods:

  • Evaluated B-Myb and E2F1 mRNA levels in primary leukemia cells and cell lines.
  • Utilized Nutlin-3 to activate p53 and observed its effect on B-Myb expression.
  • Conducted siRNA knockdown for p53 and E2F1, and miR-34a overexpression experiments.

Main Results:

  • Nutlin-3 downregulated B-Myb in p53 wild-type leukemic cells and normal cells, but not in p53-mutated/deleted cells.
  • B-Myb downregulation was essential for the G1 cell-cycle arrest induced by Nutlin-3.
  • miR-34a was identified as a key mediator in repressing B-Myb, both directly and via E2F1.

Conclusions:

  • miR-34a plays a significant role in downregulating B-Myb and E2F1, which are critical for leukemic cell proliferation.
  • Therapeutic strategies targeting miR-34a levels hold promise for treating B-cell chronic lymphocytic leukemia and acute myeloid leukemia.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...